Malaria Radical Cure Drug Efficacy Clinical Study

Department of Defense (DoD) > Defense Health Agency (DHA)

est. $117K – $1.1M

This opportunity is closed

The response deadline has passed. Review the details for future reference or to track similar opportunities.

Quick Brief

The Department of Defense, Defense Health Agency (DHA), is conducting a Malaria Radical Cure Drug Efficacy Clinical Study. The study aims to evaluate the efficacy of a new drug for treating malaria.

Generated 57d ago

Scope & Requirements

Conduct a clinical study to evaluate the efficacy of a new drug for treating malaria.

Attachments (1)

B01. Notice of Intent to Sole Source - as of 03.12.2026.pdf

PDF·51.5 KB

View all on SAM.gov

Contract Details

Estimated Value: est. $117K – $1.1M
Similar contracts award $117K – $1.1M (median $350K, 72,549 awards)Within typical range
NAICS Codes
Place of Performance: Fort Detrick, MD, USA

Agency & Contact

Contracting Organization

Agency: DEPT OF DEFENSE
Sub-Agency: DEFENSE HEALTH AGENCY (DHA)
Office: CONTRACTING DIVISION

Point of Contact

John A. Smith

Contracting Officer

[email protected]

(202) 555-0100

Key Dates

Published3mo ago

Mar 12, 2026

Last Updated3mo ago

Mar 12, 2026

Became Sources Sought3mo ago

Mar 12, 2026

Tracked

Notice of Intent to Sole Source3mo ago

Mar 12, 2026

Response Due3mo ago

Mar 20, 2026

Response Date1mo ago

Apr 25, 202608:00:00

EDT

Description

See attached PDR document. Ashley Atkins Alternative

Point of Contact Jennifer Jackson Contracting & D CONTRACTING DIVISION 1 808 SCHREIDER STREET FORT DETRICK, MD 21702 USA to this opportunity. B01. Notice of Intent to Sole Source - as of 03.12.2026.pdf

Get matched to contracts like this daily

Free AI-powered contract matching for your business.